Search research articles
Contact Us
Filters
Showing results (191-200 of 196) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 196 results.
Applied Optics
|
March 25, 2008
X-Ray Telescope Onboard Astro-E. II. Ground-Based X-Ray Characterization
R Shibata, M Ishida, H Kunieda, et al.
Applied Optics
|
March 22, 2008
X-ray telescope onboard Astro-E: optical design and fabrication of thin foil mirrors
H Kunieda, M Ishida, T Endo, et al.
Breast Cancer Research and Treatment
|
March 22, 2023
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Priya Rastogi, Gong Tang, Saima Hassan, et al.
Breast Cancer Research and Treatment
|
February 3, 2022
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer
Patricia A Ganz, Hanna Bandos, Charles E Geyer, et al.
The Lancet. Oncology
|
October 8, 2013
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
André Robidoux, Gong Tang, Priya Rastogi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)
T Shirakawa, M Shimokawa, T Otsuka, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 196) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 196 results.
Applied Optics
|
March 25, 2008
X-Ray Telescope Onboard Astro-E. II. Ground-Based X-Ray Characterization
R Shibata, M Ishida, H Kunieda, et al.
Applied Optics
|
March 22, 2008
X-ray telescope onboard Astro-E: optical design and fabrication of thin foil mirrors
H Kunieda, M Ishida, T Endo, et al.
Breast Cancer Research and Treatment
|
March 22, 2023
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Priya Rastogi, Gong Tang, Saima Hassan, et al.
Breast Cancer Research and Treatment
|
February 3, 2022
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer
Patricia A Ganz, Hanna Bandos, Charles E Geyer, et al.
The Lancet. Oncology
|
October 8, 2013
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
André Robidoux, Gong Tang, Priya Rastogi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)
T Shirakawa, M Shimokawa, T Otsuka, et al.
Page
of 20